SARAS CAPITAL
Venture capitalActively deployingCanterbury
Fund manager profile
SARAS CAPITAL is a venture fund manager based in Canterbury. SEC filings show 2 venture funds on record, most recently SARAS CAPITAL II LP filed December 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 8 of 8 portfolio companiesAI & Machine Learning ×4Enterprise Software ×4Biotech ×3SaaS ×3Data & Infrastructure ×2Deep Tech ×2Developer Tools ×2Healthtech ×2
HQs:United States×4Germany×1France×1United Kingdom×1
Investments · 8 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 14 dated
kyron.bio develops protein and antibody therapeutics using a glycan-engineering platform that controls glycosylation patterns.
BiotechDeep TechHealthtechParis, FR
Emilia McLaughlin(Cofounder)inDr. Emilia McLaughlin(CEO & Founder)
Co-investorsEntrepreneur FirstHCVCVerve VenturesGSV Ventures
Biographica (Graphica) uses multi-modal machine learning and high-throughput sequencing to identify and prioritize genetic targets for crop gene-editing, working with trait developers to design effective edits.
AgTechAI & Machine LearningBiotechLondon, GB
Cecy Price(CEO)inDominic Hall(CTO)in
Co-investorsEntrepreneur FirstFaberFaber Capital SCR SASie VenturesSuperSeedCardumen Capital+4 more
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE
Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel
Co-investorsFrontline VenturesPace VenturesY CombinatorSpringboard Health Angels
Converge is an AI-native growth platform for direct-to-consumer brands that automates media buying, attribution analysis, and reporting through agentic AI.
AdTechAI & Machine LearningDirect to ConsumerE-commerceEnterprise SoftwareSaaSNew York City, US
Jan-Henrik Lambrechts(Founder)inJerome Billiet(Founder)inThomas Holvoet(Founder)in
Co-investorsEntourage VenturesY CombinatorBessemer Venture PartnersTLV PartnersVintage Investment Partners
Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies.
AI & Machine LearningBiotechDeep TechClaymont, US
Dov Gertz(Executive Officer, Director)inOded Kalev(Executive Officer, Director)inIddo Weiner(Executive Officer)in
BoardShahar Tzafrir(Director)inAndrew Hedin(Director)in
Co-investorsBessemer Venture PartnersTLV PartnersVintage Investment Partners
Parse provides cloud-based backend infrastructure and tools for developers to build applications across mobile, desktop, and embedded platforms, including data storage, push notifications, and usage analytics.
Developer ToolsEnterprise SoftwareSan Francisco, US
Kevin Lacker(Founder/CTO)in
Co-investorsY Combinator
Parse provides an API platform that converts web actions and data retrieval from any website into single API calls without running a browser.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Alex Forman(Founder)in
Co-investorsY Combinator
Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.
Data & InfrastructureMarketing TechMedia & Entertainment
Co-investorsHaatchHorizon Technology FinanceJanus Henderson InvestorsSahsen VenturesSoleus Capital
Portfolio news
latest coverage across their companiesConverge · businessmirror.com.ph · Jul 15, 2026
Kyron · biopharminternational.com · May 15, 2026
Converge Bio · trysignalbase.com · Jan 14, 2026
Biographica · tech.eu · Jan 7, 2026
Parse · ycombinator.com · Nov 8, 2025
Frequently asked questions
- Where is SARAS CAPITAL located?
- SARAS CAPITAL is headquartered in Canterbury.






